Chief Executive Officer
Jeff has more than 20 years experience in the bioscience and industrial sectors. He has started and led companies that have developed numerous novel products in chemical and biological analysis, drug delivery, and diagnostics. Prior to Fluxion, Jeff served as President and CEO of Eksigent Technologies (acquired by Danaher), a leading supplier of microfluidic platforms for bio-analytical and medical device applications. Prior to Eksigent, Jeff held management positions in numerous functions at Raychem and Pall Corporation. Jeff received his BS from Cornell University in Chemical Engineering and graduated from the Program for Management Development at Harvard Business School.
Cristian Ionescu-Zanetti, Ph.D.
Chief Technology Officer
Cristian is an accomplished bio-physicist with 10 years of instrumentation experience in the research environment. He was most recently a post-doctoral researcher in the Bioengineering Dept. at UC Berkeley, where he invented and developed the core technology for Fluxion's microfluidic systems. Prior to that, Cristian was a post-doctoral researcher at UC Santa Barbara. Cristian has authored over 15 peer-reviewed scientific publications and presented at numerous national and international conferences. Cristian received his Ph.D. in Biophysics from UC Santa Cruz and BSc in Physics from UC Santa Barbara.
ALI YEHIA, PH.D.
VP IonFlux Product & Director of BioFlux Business Development
Ali is an experienced electrophysiologist with an extensive background in ion channels and automated patch clamp. He has been working in the automated patch clamp industry for more than 8 years. Before joining Fluxion, he worked at Sophion Bioscience for more than 5 years, first as an Application Scientist and Scientific Business Manager and ending as the Director of Sales for North America. Prior to this he held different leadership roles at the Medical Information Technology at McGill University. Ali received his PhD in Physiology (Cardiac Electrophysiology) from McGill University in Montreal, Canada and his BSc in General Biology from the American University of Beirut.
Bryan Haines, Ph.D.
Global Director, BioFlux Sales and Support
Bryan is an accomplished molecular biologist with more than 15 years of experience in the field. Before joining Fluxion he worked at The Buck Institute for Research on Aging and the University of Nevada on mechanisms of brain injury, neuroprotection and drug discovery. At Fluxion, Bryan has led BioFlux product development and supported novel research using BioFlux in the areas of vascular biology, cancer, immunology, and microbiology. Bryan completed his BSc in Biochemistry from Virginia Tech, MBA from Mount Saint Mary’s University, and earned his PhD in Cell and Molecular Biology at the University of Hawaii.